CyberKnife stereotactic radiation therapy for stage I lung cancer and pulmonary oligometastases: is fiducial implantation still relevant?-a cohort study.

Fiche publication

Date publication

septembre 2023

Journal

Journal of thoracic disease

Auteurs

Membres identifiés du Cancéropôle Est :
Pr PEIFFERT Didier , Dr FAIVRE Jean-Christophe

Tous les auteurs :
Oudin V, Salleron J, Marchesi V, Peiffert D, Khadige M, Faivre JC

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/37868838

Résumé

Few studies have investigated whether there is a difference in local control or overall survival rates following treatment with robotic stereotactic body radiation therapy (SBRT) with or without prior fiducial marker implantation. Our study aimed to investigate this in patients with primary or secondary lung tumors.